Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2004;35:964-969
Published online before print February 19, 2004, doi: 10.1161/01.STR.0000119753.05670.F1
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
35/4/964    most recent
01.STR.0000119753.05670.F1v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Erdös, B.
Right arrow Articles by Busija, D. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Erdös, B.
Right arrow Articles by Busija, D. W.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Related Collections
Right arrow Type 2 diabetes
Right arrow Glucose intolerance
Right arrow Brain Circulation and Metabolism
Right arrow Risk Factors for Stroke
Right arrow Oxidant stress

(Stroke. 2004;35:964.)
© 2004 American Heart Association, Inc.


Original Contributions

Potassium Channel Dysfunction in Cerebral Arteries of Insulin-Resistant Rats Is Mediated by Reactive Oxygen Species

Benedek Erdös, MD; Steve A. Simandle, PhD; James A. Snipes, BS; Allison W. Miller, PharmD David W. Busija, PhD

From the Department of Physiology and Pharmacology, Wake Forest University School of Medicine, Winston-Salem, NC (B.E., S.A.S., J.A.S., A.W.M., D.W.B.), and Institute of Human Physiology and Clinical Experimental Research, Semmelweis University, Budapest, Hungary (B.E.).

Correspondence to Benedek Erdös, MD, Department of Physiology and Pharmacology, Wake Forest University Health Sciences, Medical Center Blvd, Winston-Salem, NC 27157-1083. E-mail berdos{at}wfubmc.edu


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMaterials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Background and Purpose— Insulin resistance (IR) increases the risk of stroke in humans. One possible underlying factor is cerebrovascular dysfunction resulting from altered K+ channel function. Thus, the goal of this study was to examine K+ channel–mediated relaxation in IR cerebral arteries.

Methods— Experiments were performed on pressurized isolated middle cerebral arteries (MCAs) from fructose-fed IR and control rats.

Results— Dilator responses to iloprost, which are BKCa channel mediated, were reduced in the IR compared with control arteries (19±2% versus 33±2% at 10-6 mol/L). Similarly, relaxation to the KATP opener pinacidil was diminished in the IR MCAs (17±2%) compared with controls (38±2% at 10-5 mol/L). IR also reduced the KATP channel–dependent component in calcitonin gene-related peptide–induced dilation; however, the magnitude of the relaxation remained unchanged in IR because of a nonspecified K+ channel–mediated compensatory mechanism. In contrast, Kir channel–mediated relaxation elicited by increases in extracellular [K+] (4 to 12 mmol/L) was similar in the control and IR arteries. Blockade of the Kir and Kv channels with Ba2+ and 4-aminopyridine, respectively, constricted the MCAs in both experimental groups with no significant difference. Pretreatment of arteries with superoxide dismutase (200 U/mL) plus catalase (150 U/mL) restored the dilatory responses to iloprost and pinacidil in the IR arteries. Immunoblots showed that the expressions of the pore-forming subunits of the examined K+ channels are not altered by IR.

Conclusions— IR induces a type-specific K+ channel dysfunction mediated by reactive oxygen species. The alteration of KATP and BKCa channel–dependent vascular responses may be responsible for the increased risk of cerebrovascular events in IR.


Key Words: diabetes mellitus • insulin resistance • middle cerebral artery • potassium channels • oxidative stress • rats


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMaterials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Insulin resistance (IR), a major and growing medical problem in the world, is associated with vascular dysfunction, arterial hypertension, and stroke.1–6 It is estimated that {approx}24% of Americans have IR,7 and there is an escalating epidemic of IR in many developing countries, especially Asia and Africa.8 Despite considerable attention given to IR (>18 000 scientific papers and numerous newspaper articles), effects on the cerebral circulation are virtually unexplored. In previous studies, we provided evidence that IR in a fructose-fed rat model led to impairment of endothelium-dependent dilator responses in isolated middle cerebral arteries (MCAs)9 and that it can be related to the dysfunction of smooth muscle K+ channels.10 However, our evidence for impaired K+ channel function was indirect; we did not examine all relevant types of K+ channels; and the mechanisms of K+ channel dysfunction remained to be clarified.

The goal of this study was to directly evaluate K+ channel–mediated vascular responses in isolated MCAs from IR fructose-fed and control rats in response to agonists and inhibitors of the large-conductance Ca2+-activated (BKCa), ATP-dependent (KATP), inward rectifier (Kir), and voltage-dependent (Kv) potassium channels. Because IR-induced oxidative stress is thought to be a major factor leading to vascular dysfunction in the peripheral and coronary circulations11–16 and reactive oxygen species (ROS) were shown to inhibit K+ channel function in the cerebral vasculature,17–19 we also examined whether the altered K+ channel–mediated responses in IR can be restored by treatment of the arteries with ROS scavengers. Finally, we tested the hypothesis that IR alters the expression of and thus the density of the K+ channels in the cerebral arteries, leading to reduced total K+ efflux when widespread channel activation occurs.


*    Materials and Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Materials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Animal Preparation
Protocols were approved by the Animal Care and Use Committee at Wake Forest University Health Sciences. Male Sprague-Dawley rats were obtained at 6 weeks of age and randomized into control (n=46) and IR (n=48) groups. Animals in the IR group were fed a fructose-rich diet containing (as percentage of total calorie intake) 66% fructose, 22% casein, and 12% lard (Harlan Teklad). Control animals received standard rat chow that contained no fructose, 26% casein, and 14% lard. After 4 weeks, fasted rats were anesthetized with pentobarbital sodium (50 mg/kg IP) and anticoagulated with heparin sodium (500 U IP). After decapitation, the brain was immediately removed and placed in cold, oxygenated modified Krebs-Ringer bicarbonate solution containing (mmol/L) NaCl 119, KCl 4.7, NaHCO3 24, KH2PO4 1.18, MgSO4 1.17, EDTA 0.026, CaCl2 1.6, and glucose 5.5.

Isolation and Cannulation of the Arteries
These methods have been described previously in detail.9,10 Briefly, a section of the MCA was transferred to a vessel chamber and mounted between 2 glass micropipettes. Oxygenated (20% O2/5% CO2/75% N2; 37°C) Krebs’ solution was continuously circulated through the vessel bath. The lumen of the artery was filled with Krebs’ solution; 1 micropipette was clamped off, and the other was connected to an elevated reservoir to maintain a constant intraluminal pressure of 80 mm Hg. Drugs were added abluminally into the bath solution. Only 1 experiment was performed per artery.

Measurement of Vascular Responses
Concentration-response experiments were performed with the following drugs: iloprost (10-8 to 10-6 mol/L), calcitonin gene-related peptide (CGRP; 10-10 to 3x10-8 mol/L), and pinacidil (10-7 to 10-5 mol/L). Furthermore, responses to increases in K+ concentration in the Krebs’ solution (4 to 12 mmol/L; osmolarity was adjusted with Na+) were examined. Roles of the different K+ channels were evaluated with the nonselective K+ channel inhibitor tetraethyl ammonium chloride (TEA; 2.5 mmol/L) and with these selective inhibitors of the BKCa, KATP, Kv, and Kir channels: iberiotoxin (0.1 µmol/L), glibenclamide (10 µmol/L), 4-aminopyridine (4-AP; 0.1 to 1 mmol/L), and Ba2+ (20 to 120 µmol/L), respectively. To scavenge ROS, arteries were treated with the combination of superoxide dismutase (SOD; 200 U/mL) and catalase (150 U/mL).

Chemicals
TEA, iberiotoxin, glibenclamide, pinacidil, and 4-AP were purchased from Sigma. CGRP was obtained from American Peptide Inc. Iloprost was purchased from Schering AG. Drugs were dissolved in Krebs’ solution except for pinacidil and glibenclamide, which were dissolved in dimethyl sulfoxide and Krebs’ solution. The same concentration of dimethyl sulfoxide alone had no effect on vessel diameter.

Evaluation of K+ Channel Expression by Immunoblotting
Protein samples of MCAs from control and IR rats were prepared as previously described.20 An equal amount of protein for each sample was separated by 10% sodium dodecyl sulfate–polyacrylamide gel electrophoresis, transferred onto a polyvinylidine difluoride membrane, and blocked with 5% skimmed milk powder (for BKCaa and Kir2.1) or 3% bovine serum albumin (for Kir6.1 and 6.2) in Tris-buffered saline containing 0.1% Tween 20. Blots were incubated overnight at 4°C with 1 of the following antibodies: anti-BKCa{alpha} (BD Transduction Laboratories, 1:1000 dilution), anti-Kir2.1 (Sigma, 1:500 dilution), anti-Kir6.1, or anti-Kir6.2 (Santa Cruz Biotechnology Inc, 1:500 dilution). The bound antibodies were detected by chemiluminescence.

Biochemical Measurements
Plasma insulin and glucose levels were measured after a 12-hour fast with a rat insulin enzyme-linked immunosorbent assay kit (Crystal Chem. Inc) and Trinder reagent (Sigma), respectively. Fasting glucose levels were similar between the 2 groups (127±7 and 132±4 mg/dL for control and IR rats, respectively), whereas insulin was markedly increased in the IR rats (1809±270 pg/mL) compared with controls (478±61 pg/mL, P<0.05). The mean body weight was similar in the 2 groups of animals (315±8 and 310±7 g for control and IR rats, respectively).

Statistical Analysis
All data are expressed as mean±SE. The magnitudes of spontaneous vascular tone and treatment-induced vasoconstriction were calculated as percentages of maximal intraluminal diameter; vascular relaxations were calculated as percentages of the spontaneously developed tone. Concentration-response curves were evaluated at each concentration for differences between treated and untreated arteries from control and IR groups by use of analysis of variance, followed by Tukey’s post hoc test. The criterion for significance was P<0.05.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
*Results
down arrowDiscussion
down arrowReferences
 
The maximal intraluminal diameter of the MCAs did not differ between the 2 groups (230±2 µm for control [n=83] versus 226±1 µm for IR [n=78]). The spontaneously developed tone was also similar; the MCAs constricted to 69±1% and 71±1% of the initial diameter in the control and IR groups, respectively.

K+ Channel–Mediated Vascular Responses in IR
Iloprost induced concentration-dependent relaxation in both control and IR MCAs; however, responses were significantly reduced in the IR group (Figure 1). Maximum relaxation to iloprost (10-6 mol/L) was 33±2% in control MCAs (n=7) while only 19±2% in the IR arteries (n=6, P<0.01). Application of the nonselective TEA or the BKCa-selective inhibitor iberiotoxin inhibited these responses in both control and IR arteries (Figure 1). Glibenclamide had no effect on the iloprost-induced dilation in either of the 2 experimental groups; maximum relaxations were 32±3% and 20±3% in the control (n=6) and IR (n=6) arteries, respectively.



View larger version (26K):
[in this window]
[in a new window]
 
Figure 1. Cumulative dose-response curves to iloprost, and effects of TEA and iberiotoxin (IBTX) treatment. *P<0.01 vs control.

Pinacidil induced dose-dependent relaxations in the MCAs (Figure 2A); however, maximum dilation in the IR arteries (17±2%, n=7) was significantly reduced compared with controls (38±2%, n=6, P<0.01). Glibenclamide completely inhibited these relaxations in both experimental groups. CGRP-induced dilator responses were comparable between the control and IR arteries (Figure 2B). Maximum relaxations in response to CGRP (10-8 mol/L) were 33±2% in the control (n=9) and 27±2% in IR (n=9) MCAs. Glibenclamide significantly diminished the CGRP-induced dilation in the control arteries, but the blockade of the KATP channels had no effect in the IR MCAs (relaxation at 10-8 mol/L, 12±2% in control [n=8] versus 27±3% in IR [n=6] arteries). Other K+ channel inhibitors (ie, TEA, Ba2+, 4-AP, ouabain) had no effect on the CGRP-induced responses in either the control or IR groups (data not shown); however, an increase in extracellular K+ level to 50 mmol/L completely inhibited the vascular responses to CGRP in both control and IR arteries (Figure 2B).



View larger version (20K):
[in this window]
[in a new window]
 
Figure 2. Cumulative dose-response curves to pinacidil (A) and CGRP (B), and effects of glibenclamide (GLIB) and KCl. *P<0.01 vs untreated or control.

Elevations of the K+ concentration in the Krebs’ solution caused relaxation in the control and IR MCAs with similar dose-response relationships (Figure 3A). For example, the relaxation at 8 mmol/L K+ concentration was 42±7% in the control (n=10) and 45±9% in the IR (n=8) MCAs. Ba2+ (100 µmol/L) completely inhibited the K+-induced responses in both groups. Furthermore, at normal K+ concentration, Ba2+ induced dose-dependent constrictions in both the control and IR arteries (Figure 3B). For example, constriction to 120 µmol/L Ba2+ was 15±1% in control (n=7) and 20±2% in IR (n=6) MCAs.



View larger version (16K):
[in this window]
[in a new window]
 
Figure 3. Cumulative dose-response curves to K+ (A) and Ba2+ (B). *P<0.01 vs untreated.

4-AP increased the spontaneously developed tone similarly in the control and IR arteries. Constriction to 100, 400, 700, and 1000 µmol/L 4-AP was 3±1% and 4±1%, 7±1% and 6±1%, 9±1% and 9±1%, and 12±1% and 13±2% in the control (n=6) and IR (n=6) MCAs, respectively.

Mechanisms of K+ Channel Impairment in IR
Western immunoblots with antibodies directed against the BKCa{alpha}, Kir2.1, and Kir6.1 to Kri6.2 subunits revealed that IR had no detectable effect on the expression of these proteins (Figure 4). Pretreatment of the arteries with a combination of SOD and catalase restored the impaired vascular responses to iloprost in the IR MCAs (Figure 5A). For example, relaxation to 10-6 mol/L iloprost was 40±12% (n=6) in control and 46±6% in IR (n=6) arteries. After the same treatment, pinacidil-induced relaxation increased in both the control and IR groups, but this increase was more significant in the IR arteries, resulting in comparable responses in the control and IR MCAs (Figure 5B). For example, relaxation to 10-5 mol/L pinacidil was 57±10% (n=6) in control and 64±9% in IR (n=6) arteries.



View larger version (84K):
[in this window]
[in a new window]
 
Figure 4. Western blot analysis of BKCa{alpha} subunit of BKCa channel, Kir2.1 subunit of Kir channel, and Kir6.1 and Kir6.2 subunits of KATP channel. Each lane was loaded with equal amount of protein (7 µg) from isolated MCAs. Densities of the immunoreactive bands corresponding to examined K+ channel subunits were similar in control and IR arteries.



View larger version (35K):
[in this window]
[in a new window]
 
Figure 5. Effects of SOD (200 U/mL) plus catalase (CAT, 150 U/mL) treatment on iloprost- (A) and pinacidil- (B) induced relaxation. *P<0.01 (IR vs control); #P<0.01 vs untreated.


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
up arrowResults
*Discussion
down arrowReferences
 
The major finding of this study is that IR induces a type-specific K+ channel dysfunction in the MCAs of fructose-fed rats involving the BKCa and KATP channels, whereas the function of the Kir and Kv channels remains intact. The revealed alterations in BKCa and KATP channel–mediated relaxation are due to the oxidative stress elicited by IR and can be restored by scavenging ROS. IR does not influence the expression of the pore-forming subunits of the examined K+ channels; thus, changes in channel density are unlikely to play a significant role in the reduced K+ channel–mediated responses.

Effect of IR on K+ Channel–Mediated Relaxation
BKCa channel dysfunction has been reported previously in mesenteric and coronary arteries of fructose-fed IR rats.21–23 We demonstrated in this study that dilator responses to iloprost, a stable prostacyclin analog that acts via opening of BKCa channels, are also reduced in the MCAs of IR rats compared with controls. This finding supports our earlier observations that the contribution of BKCa channels in the control of resting vascular tone is reduced and that endothelium-dependent relaxation mediated by a cyclooxygenase-derived substance such as prostacyclin and the activation of the BKCa channels is impaired in the MCAs of IR rats.9,10

We have previously found that KATP channel function is altered by IR in the cerebral arteries.10 We extended these earlier studies by using the selective KATP opener pinacidil and CGRP, an endogenous substance released from perivascular nerves that dilates cerebral arteries via opening KATP channels.24 Similar to our previous results with cromakalim,10 pinacidil-induced dilator responses were reduced in the MCAs of IR rats compared with controls. However, relaxation to CGRP, which was also mediated by KATP channels in the control MCAs as indicated by the diminished responses in the presence of glibenclamide, was similar in the control and IR groups. This was a surprising finding, considering the previously revealed impairment of the KATP channels, but could be explained by a shift to an alternative vascular signaling mechanism in response to chronic attenuation of the KATP channels by IR. This hypothesis is supported by the finding that in contrast to control arteries, glibenclamide treatment had no effect on the CGRP-induced dilation in the IR MCAs. These results could not be attributed to a decreased effectiveness of glibenclamide on KATP channels of the IR arteries because the same treatment completely abolished the pinacidil-induced dilation even in the IR MCAs. On the other hand, a high concentration of K+, which sets the equilibrium potential to K+ equal to the membrane potential, completely abolished dilator responses to CGRP in both groups, suggesting that the relaxation was mediated by K+ channel activation and subsequent hyperpolarization. Yet, none of the other K+ channel inhibitors (ie, TEA, Ba2+, 4-AP, ouabain) was able to alter CGRP-induced relaxation in the IR MCAs. Thus, although the exact nature of the dilator mechanism mediating responses to CGRP in IR MCAs is not known at this time, these findings indicate a role of a compensating signaling pathway, which involves the opening of a presently undefined K+ channel and mediates responses to endogenously present substances such as CGRP but not to selective openers and inhibitors of well-defined K+ channels.

We are unaware of previous studies examining Kir and Kv channel–mediated responses in IR arteries despite the fact that these ion channels play an important role in the regulation of vascular function both in the cerebral circulation and in other vascular beds.25–28 Our data indicate that unlike the BKCa and KATP channels, Kir and Kv channel–mediated vascular responses are not affected by IR.

Mechanisms of K+ Channel Impairment in IR
We considered 2 mechanisms to account for impaired BKCa and KATP channel function in IR. First, we examined whether IR alters the expression of and, as a result, the density of these K+ channels in the cerebral arteries, leading to reduced total K+ efflux when widespread channel activation occurs. For example, a previous study had shown that expression of BKCa channels is altered in cerebral arteries in pathophysiological conditions.20 However, using immunoblot analysis, we found that levels of the pore-forming subunits of the BKCa, KATP, and Kir channels are not detectably affected by IR. These findings are consistent with the results of a previous study29 in which the expression of the BKCa{alpha} subunit in mesenteric arteries was found to be unaffected by IR.

Because increased production of ROS has been reported in various circulatory beds of IR or diabetic humans13–15 and animals11,12,16 and because K+ channel function is inhibited by ROS in various pathophysiological conditions,17–19,30 our second approach was to examine the contribution of ROS to BKCa and KATP channel dysfunction in IR. We found that coapplication of SOD and catalase restored normal dilator responses in the IR MCAs to iloprost, pinacidil, and cromakalim (not shown). Thus, it seems that continuous production of ROS, probably superoxide anion and/or hydrogen peroxide, exerts a constant inhibitory effect on BKCa and KATP channels in the cerebral arteries of IR rats. The finding that an acute treatment with ROS scavengers is able to restore these dilator responses also suggests that the ROS-induced inhibition is reversible, at least at this stage of IR. This view is supported by patch-clamp studies performed in myocytes from IR mesenteric arteries23 that revealed that agonist-induced activation of the BKCa channel was normal when the membrane patch was separated from the cell in an inside-out configuration. In the same study, when function of the BKCa channel was examined in a cell-attached configuration, activation of the channel was impaired, implying an inhibitory effect of endogenous cytosolic substances. From our present findings, we suggest that this inhibition of the BKCa and KATP channels is mediated by ROS. Why Kir and Kv channels, which have been previously reported to be impaired by ROS or by conditions consistent with ROS formation such as ischemia/reperfusion,19,30–32 are not similarly affected by IR is unclear but may involve different amounts, production sites, or types of ROS. To the best of our knowledge, our results are the first to show that in addition to the previously described ROS-induced endothelial dysfunction,11,12,15 ROS produced in response to IR is also able to affect vascular smooth muscle function by inhibiting K+ channel–mediated hyperpolarization and relaxation.

In summary, we demonstrated the diverse effects of IR on vascular smooth muscle K+ channels. For example, Kir and Kv channels are largely unaffected by IR, and stimuli that activate these channels will exert normal dilator responses. On the other hand, BKCa and KATP channel functions are severely impaired in IR, and dilator responses of the cerebral arteries mediated by these ion channels are reduced. Furthermore, in the case of CGRP, IR may lead to a change in cellular signaling pathways mediating arterial dilation. The implication of these findings is that IR, even in the absence of diabetes, can compromise normal vasodilator function of the cerebral arteries. Thus, the cerebral resistance vessels will not be able to respond normally to a variety of endogenous metabolic stimuli, which could lead to a mismatch between blood flow and metabolic rate. Additionally, reduced BKCa and KATP channel function may prevent appropriate compensatory vascular responses in pathophysiological conditions such as cerebrovascular occlusive disease, hemorrhagic stroke, or changes in blood pressure.


*    Acknowledgments
 
This research was supported by NIH grants HL-30260, HL-46558, HL-50587 (D.W.B.); HL-66074, HL-65380 (A.W.M.); AHA Mid-Atlantic Affiliate Grant 9951272U (D.W.B.), AHA Bugher Foundation Award 0270114N (D.W.B.), and the Hungarian OTKA (T 29169, T 90665, T 97334, T 37885) and ETT 218/2001. Dr Erdös was supported by a Hungarian National Eötvös scholarship.

Received November 10, 2003; revision received December 10, 2003; accepted December 15, 2003.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
up arrowResults
up arrowDiscussion
*References
 
1. Steinberg HO, Baron AD. Vascular function, insulin resistance and fatty acids. Diabetologia. 2002; 45: 623–634.[CrossRef][Medline] [Order article via Infotrieve]

2. Salonen JT, Lakka TA, Lakka HM, Valkonen VP, Everson SA, Kaplan GA. Hyperinsulinemia is associated with the incidence of hypertension and dyslipidemia in middle-aged men. Diabetes. 1998; 47: 270–275.[Abstract]

3. Jorgensen H, Nakayama H, Raaschou HO, Olsen TS. Stroke in patients with diabetes: the Copenhagen Stroke Study. Stroke. 1994; 25: 1977–1984.[Abstract]

4. Shinozaki K, Naritomi H, Shimizu T, Suzuki M, Ikebuchi M, Sawada T, Harano Y. Role of insulin resistance associated with compensatory hyperinsulinemia in ischemic stroke. Stroke. 1996; 27: 37–43.[Abstract/Free Full Text]

5. Matsumoto K, Miyake S, Yano M, Ueki Y, Miyazaki A, Hirao K, Tominaga Y. Insulin resistance and classic risk factors in type 2 diabetic patients with different subtypes of ischemic stroke. Diabetes Care. 1999; 22: 1191–1195.[Abstract/Free Full Text]

6. Megherbi SE, Milan C, Minier D, Couvreur G, Osseby GV, Tilling K, Di Carlo A, Inzitari D, Wolfe CD, Moreau T, Giroud M. Association between diabetes and stroke subtype on survival and functional outcome 3 months after stroke: data from the European BIOMED Stroke Project. Stroke. 2003; 34: 688–694.[Abstract/Free Full Text]

7. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002; 287: 356–359.[Abstract/Free Full Text]

8. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001; 414: 782–787.[CrossRef][Medline] [Order article via Infotrieve]

9. Erdös B, Miller AW, Busija DW. Impaired endothelium-mediated relaxation in isolated cerebral arteries from insulin-resistant rats. Am J Physiol Heart Circ Physiol. 2002; 282: H2060–H2065.[Abstract/Free Full Text]

10. Erdös B, Miller AW, Busija DW. Alterations in KATP and KCa channel function in cerebral arteries of insulin-resistant rats. Am J Physiol Heart Circ Physiol. 2002; 283: H2472–H2477.[Abstract/Free Full Text]

11. Kashiwagi A, Shinozaki K, Nishio Y, Okamura T, Toda N, Kikkawa R. Free radical production in endothelial cells as a pathogenetic factor for vascular dysfunction in the insulin resistance state. Diabetes Res Clin Pract. 1999; 45: 199–203.[CrossRef][Medline] [Order article via Infotrieve]

12. Shinozaki K, Kashiwagi A, Nishio Y, Okamura T, Yoshida Y, Masada M, Toda N, Kikkawa R. Abnormal biopterin metabolism is a major cause of impaired endothelium-dependent relaxation through nitric oxide/O2-imbalance in insulin-resistant rat aorta. Diabetes. 1999; 48: 2437–2445.[Abstract]

13. Guzik TJ, Mussa S, Gastaldi D, Sadowski J, Ratnatunga C, Pillai R, Channon KM. Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation. 2002; 105: 1656–1662.[Abstract/Free Full Text]

14. Perticone F, Ceravolo R, Candigliota M, Ventura G, Iacopino S, Sinopoli F, Mattioli PL. Obesity and body fat distribution induce endothelial dysfunction by oxidative stress: protective effect of vitamin C. Diabetes. 2001; 50: 159–165.[Abstract/Free Full Text]

15. Shinozaki K, Hirayama A, Nishio Y, Yoshida Y, Ohtani T, Okamura T, Masada M, Kikkawa R, Kodama K, Kashiwagi A. Coronary endothelial dysfunction in the insulin-resistant state is linked to abnormal pteridine metabolism and vascular oxidative stress. J Am Coll Cardiol. 2001; 38: 1821–1828.[Abstract/Free Full Text]

16. Bagi Z, Koller A, Kaley G. Superoxide-NO interaction decreases flow- and agonist-induced dilations of coronary arterioles in type 2 diabetes mellitus. Am J Physiol Heart Circ Physiol. 2003; 285: H1404–H1410.[Abstract/Free Full Text]

17. Bari F, Louis TM, Meng W, Busija DW. Global ischemia impairs ATP-sensitive K+ channel function in cerebral arterioles in piglets. Stroke. 1996; 27: 1874–1880.[Abstract/Free Full Text]

18. Armstead WM. Vasopressin induced cyclooxygenase dependent superoxide generation contributes to K(+) channel function impairment after brain injury. Brain Res. 2001; 910: 19–28.[CrossRef][Medline] [Order article via Infotrieve]

19. Liu Y, Gutterman DD. Oxidative stress and potassium channel function. Clin Exp Pharmacol Physiol. 2002; 29: 305–311.[CrossRef][Medline] [Order article via Infotrieve]

20. Liu Y, Hudetz AG, Knaus HG, Rusch NJ. Increased expression of Ca2+-sensitive K+ channels in the cerebral microcirculation of genetically hypertensive rats: evidence for their protection against cerebral vasospasm. Circ Res. 1998; 82: 729–737.[Abstract/Free Full Text]

21. Katakam PV, Ujhelyi MR, Miller AW. EDHF-mediated relaxation is impaired in fructose-fed rats. J Cardiovasc Pharmacol. 1999; 34: 461–467.[CrossRef][Medline] [Order article via Infotrieve]

22. Miller AW, Katakam PV, Ujhelyi MR. Impaired endothelium-mediated relaxation in coronary arteries from insulin-resistant rats. J Vasc Res. 1999; 36: 385–392.[CrossRef][Medline] [Order article via Infotrieve]

23. Miller AW, Dimitropoulou C, Han G, White RE, Busija DW, Carrier GO. Epoxyeicosatrienoic acid-induced relaxation is impaired in insulin resistance. Am J Physiol Heart Circ Physiol. 2001; 281: H1524–H1531.[Abstract/Free Full Text]

24. Nelson MT, Huang Y, Brayden JE, Hescheler J, Standen NB. Arterial dilations in response to calcitonin gene-related peptide involve activation of K+ channels. Nature. 1990; 344: 770–773.[CrossRef][Medline] [Order article via Infotrieve]

25. Knot HJ, Nelson MT. Regulation of membrane potential and diameter by voltage-dependent K+ channels in rabbit myogenic cerebral arteries. Am J Physiol. 1995; 269: H348–H355.[Medline] [Order article via Infotrieve]

26. Johnson TD, Marrelli SP, Steenberg ML, Childres WF, Bryan RM. Inward rectifier potassium channels in the rat middle cerebral artery. Am J Physiol Regul Integr Comp Physiol. 1998; 274: R541–R547.[Abstract/Free Full Text]

27. Bradley KK, Jaggar JH, Bonev AD, Heppner TJ, Flynn ER, Nelson MT, Horowitz B. Kir2.1 encodes the inward rectifier potassium channel in rat arterial smooth muscle cells. J Physiol. 1999; 515: 639–651.[Abstract/Free Full Text]

28. Faraci FM, Sobey CG. Role of potassium channels in regulation of cerebral vascular tone. J Cereb Blood Flow Metab. 1998; 18: 1047–1063.[CrossRef][Medline] [Order article via Infotrieve]

29. Dimitropoulou C, Han G, Miller AW, Molero M, Fuchs LC, White RE, Carrier GO. Potassium (BK(Ca)) currents are reduced in microvascular smooth muscle cells from insulin-resistant rats. Am J Physiol Heart Circ Physiol. 2002; 282: H908–H917.[Abstract/Free Full Text]

30. Ciorba MA, Heinemann SH, Weissbach H, Brot N, Hoshi T. Modulation of potassium channel function by methionine oxidation and reduction. Proc Natl Acad Sci U S A. 1997; 94: 9932–9937.[Abstract/Free Full Text]

31. Marrelli SP, Johnson TD, Khorovets A, Childres WF, Bryan RM Jr. Altered function of inward rectifier potassium channels in cerebrovascular smooth muscle after ischemia/reperfusion. Stroke. 1998; 29: 1469–1474.[Abstract/Free Full Text]

32. Bastide M, Bordet R, Pu Q, Robin E, Puisieux F, Dupuis B. Relationship between inward rectifier potassium current impairment and brain injury after cerebral ischemia/reperfusion. J Cereb Blood Flow Metab. 1999; 19: 1309–1315.[CrossRef][Medline] [Order article via Infotrieve]




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
A. Nadeem, D. S. Ponnoth, H. R. Ansari, T. P. Batchelor, R. D. Dey, C. Ledent, and S. J. Mustafa
A2A Adenosine Receptor Deficiency Leads to Impaired Tracheal Relaxation via NADPH Oxidase Pathway in Allergic Mice
J. Pharmacol. Exp. Ther., July 1, 2009; 330(1): 99 - 108.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
P. V. G. Katakam, F. Domoki, J. A. Snipes, A. R. Busija, Y. P. R. Jarajapu, and D. W. Busija
Impaired mitochondria-dependent vasodilation in cerebral arteries of Zucker obese rats with insulin resistance
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2009; 296(2): R289 - R298.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
H. Kinoshita, N. Matsuda, H. Kaba, N. Hatakeyama, T. Azma, K. Nakahata, Y. Kuroda, K. Tange, H. Iranami, and Y. Hatano
Roles of Phosphatidylinositol 3-Kinase-Akt and NADPH Oxidase in Adenosine 5'-Triphosphate-Sensitive K+ Channel Function Impaired by High Glucose in the Human Artery
Hypertension, September 1, 2008; 52(3): 507 - 513.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. K. Harris, M. M. Elgebaly, W. Li, K. Sachidanandam, and A. Ergul
Effect of chronic endothelin receptor antagonism on cerebrovascular function in type 2 diabetes
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2008; 294(4): R1213 - R1219.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
N. Erdei, Z. Bagi, I. Edes, G. Kaley, and A. Koller
H2O2 increases production of constrictor prostaglandins in smooth muscle leading to enhanced arteriolar tone in Type 2 diabetic mice
Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H649 - H656.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
H. Xu, W. F. Jackson, G. D. Fink, and J. J. Galligan
Activation of Potassium Channels by Tempol in Arterial Smooth Muscle Cells From Normotensive and Deoxycorticosterone Acetate-Salt Hypertensive Rats
Hypertension, December 1, 2006; 48(6): 1080 - 1087.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
W. Zhou, X.-L. Wang, K. G. Lamping, and H.-C. Lee
Inhibition of Protein Kinase Cbeta Protects against Diabetes-Induced Impairment in Arachidonic Acid Dilation of Small Coronary Arteries
J. Pharmacol. Exp. Ther., October 1, 2006; 319(1): 199 - 207.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
A. N. Lyle and K. K. Griendling
Modulation of vascular smooth muscle signaling by reactive oxygen species.
Physiology, August 1, 2006; 21: 269 - 280.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
H. Kinoshita, T. Azma, H. Iranami, K. Nakahata, Y. Kimoto, M. Dojo, O. Yuge, and Y. Hatano
Synthetic Peroxisome Proliferator-Activated Receptor-{gamma} Agonists Restore Impaired Vasorelaxation via ATP-Sensitive K+ Channels by High Glucose
J. Pharmacol. Exp. Ther., July 1, 2006; 318(1): 312 - 318.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. P. Burnham, I. T. Johnson, and A. H. Weston
Reduced Ca2+-dependent activation of large-conductance Ca2+-activated K+ channels from arteries of Type 2 diabetic Zucker diabetic fatty rats
Am J Physiol Heart Circ Physiol, April 1, 2006; 290(4): H1520 - H1527.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. Erdos, J. A. Snipes, C. D. Tulbert, P. Katakam, A. W. Miller, and D. W. Busija
Rosuvastatin improves cerebrovascular function in Zucker obese rats by inhibiting NAD(P)H oxidase-dependent superoxide production
Am J Physiol Heart Circ Physiol, March 1, 2006; 290(3): H1264 - H1270.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
H. Xu, X. Bian, S. W. Watts, and A. Hlavacova
Activation of Vascular BK Channel by Tempol in DOCA-Salt Hypertensive Rats
Hypertension, November 1, 2005; 46(5): 1154 - 1162.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
G. D'Angelo, A. A. Elmarakby, D. M. Pollock, and D. W. Stepp
Fructose Feeding Increases Insulin Resistance but Not Blood Pressure in Sprague-Dawley Rats
Hypertension, October 1, 2005; 46(4): 806 - 811.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
C. L. Oltman, L. J. Coppey, J. S. Gellett, E. P. Davidson, D. D. Lund, and M. A. Yorek
Progression of vascular and neural dysfunction in sciatic nerves of Zucker diabetic fatty and Zucker rats
Am J Physiol Endocrinol Metab, July 1, 2005; 289(1): E113 - E122.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. D. Gutterman, H. Miura, and Y. Liu
Redox Modulation of Vascular Tone: Focus of Potassium Channel Mechanisms of Dilation
Arterioscler. Thromb. Vasc. Biol., April 1, 2005; 25(4): 671 - 678.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
F. M. Faraci
Oxidative Stress: The Curse That Underlies Cerebral Vascular Dysfunction?
Stroke, February 1, 2005; 36(2): 186 - 188.
[Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. A. Phillips, F. A. Sylvester, and J. C. Frisbee
Oxidant stress and constrictor reactivity impair cerebral artery dilation in obese Zucker rats
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2005; 288(2): R522 - R530.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
B. Erdos, J. A. Snipes, B. Kis, A. W. Miller, and D. W. Busija
Vasoconstrictor mechanisms in the cerebral circulation are unaffected by insulin resistance
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2004; 287(6): R1456 - R1461.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
35/4/964    most recent
01.STR.0000119753.05670.F1v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Erdös, B.
Right arrow Articles by Busija, D. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Erdös, B.
Right arrow Articles by Busija, D. W.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Related Collections
Right arrow Type 2 diabetes
Right arrow Glucose intolerance
Right arrow Brain Circulation and Metabolism
Right arrow Risk Factors for Stroke
Right arrow Oxidant stress